Posts Tagged ‘ethical issues’

Valuing the good, the bad and the ugly

Author: David Kent, 08/29/17

As with all of my posts that relate to anything that might end up being a medical treatment, it is important to be very clear that I am scientist and not a physician.  My comments are my own opinion and based on my experience as a stem cell biologist over the last 10+ years. This…Read more

An ivory tower perspective of the right-to-try movement: We need to balance the equation

Author: Guest, 08/29/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Do desperate times call for desperate measures in the context…Read more

Right Turn: ‘Right to try’ state of affairs in U.S.

Author: Stacey Johnson, 08/25/17

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S….Read more

Weighing in on a controversial topic

Author: Stacey Johnson, 08/23/17

We are less than one week away from Signals’ second blog carnival! Last month I promised to reveal the topic and the participants. I also hinted that this year’s topic might strike some readers as controversial. Given that a few invited bloggers declined to participate, I’d have to say that’s the case. So although our…Read more

Would you buy a designer bag made from lab-grown human skin?

Author: Jovana Drinjakovic, 10/06/16

In case you haven’t heard, Tina Gorjanc, a UK-based fashion designer, shocked the fashion world this summer when she announced her Pure Human collection of luxury leather items, to be made from lab-grown human skin, engineered with the late designer Alexander McQueen’s DNA. I know, it makes your brain twist in on itself! As you…Read more

Taking appropriate steps towards gene editing in Canada

Author: Guest, 09/29/16

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in August, I had the pleasure of attending a gene editing/CRISPR workshop, hosted by…Read more

Controversial “three-person embryos” should be approved for clinical trials in the U.S.

Author: Nicole Forgione, 03/31/16

Stem cell technology and reproductive medicine have always been tightly linked. After all, the early embryo is essentially a ball of stem cells. For this post, I will delve into a hot topic in reproductive medicine—three-person embryos. Similar to what we have seen with many cell therapies, this technology illustrates the potential of discoveries in…Read more